Fountain Report Excerpts Sep 24, 2024
Elanco Animal Health announced the FDA approved Zenrelia™, a once-daily oral JAK inhibitor for control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. The approval enters Elanco into the estimated $1.7 billion global canine dermatology market. So far this year, just more than [...]
Read More